You are using an older browser version. Please use a supported version for the best MSN experience.

Second coronavirus vaccine found to be MORE effective than Pfizer's

Birmingham Mail logo Birmingham Mail 16/11/2020 James Rodger

British scientists have hailed the "tremendously exciting" news that a US coronavirus vaccine may prevent 94.5% of people from getting Covid-19.

Interim data from the US firm Moderna suggests its vaccine is highly effective in preventing people getting ill and also works across all age groups, including the elderly.

The UK has not placed an order for the vaccine - which works in a similar way to Pfizer's - and it is unclear whether the British Government can get any stock.

But scientists said the news bodes well for other Covid-19 vaccines, with the one for Oxford University and UK pharmaceutical giant AstraZeneca due to report in the coming days or weeks.

Moderna intends to submit an application for an Emergency Use Authorisation with the US Food and Drug Administration shortly and will submit further data on the vaccine's effectiveness and safety.

There are more than 200 candidates being tested around the world.

About 12 are in in the final stages of testing, but the one from German firm BioNTech and US pharmaceutical company Pfizer is the first to report any results.

There are two frontrunners in the vaccine race - the one from Pfizer, called BNT162b2, and another being developed by the University of Oxford and AstraZeneca, which is also in phase three clinical trials.

It is thought results of the Oxford-AstraZeneca trials will be released before Christmas.

Other potential vaccines in phase three trials have been developed by US drugs firm Moderna and biotech company Novavax.

And on Wednesday Russia announced that early data for its Sputnik V vaccine suggest it is 92% effective.


More from Birmingham Mail

Birmingham Mail
Birmingham Mail
image beaconimage beaconimage beacon